{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-016562","form_type":"8-K","ticker":"WGRX","cik":"0002030763","company_name":"Wellgistics Health, Inc.","filed_at":"2025-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.392638+00:00","generated_at":"2026-05-17T05:09:32.000793+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Wellgistics prices $5M offering (7.14M shares + warrants at $0.70), partners with TheracosBio on Brenzavvy","bullets":["Public offering of 7,142,862 common shares and warrants to purchase an equal number, at $0.70 per unit; gross proceeds ~$5M.","Offering closed Sept 29; H.C. Wainwright acted as placement agent, receiving $350K fee and 500K warrants at $0.875.","Company to use net proceeds for working capital, R&D, and potential acquisitions.","Strategic collaboration with TheracosBio to distribute diabetes drug Brenzavvy (bexagliflozin) via 6,500+ pharmacies starting Q4 2025.","Partnership aims to lower patient costs by bypassing PBMs; Q4 rollout expected to generate near-term revenue."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-016562","json":"https://secwatch.observer/filing/0001493152-25-016562.json","markdown":"https://secwatch.observer/filing/0001493152-25-016562.md","text":"https://secwatch.observer/filing/0001493152-25-016562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030763/000149315225016562/0001493152-25-016562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030763/000149315225016562/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:09:32.000793+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}